TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

IO Biotech Presents Pre-Clinical Data Highlighting the Potential of Additional Therapeutic Cancer Vaccine Candidates at the 2025 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

GlobeNewswire Inc. Logo GlobeNewswire Inc. • •By Io Biotech
IO Biotech Presents Pre-Clinical Data Highlighting the Potential of Additional Therapeutic Cancer Vaccine Candidates at the 2025 Annual Meeting of the Society for Immunotherapy of Cancer (SITC)

IO Biotech presented pre-clinical data on two therapeutic cancer vaccine candidates, IO112 and IO170, at the Society for Immunotherapy of Cancer's Annual Meeting. The candidates target arginase 1 and TGF-β, demonstrating potential anti-tumor activities and immune microenvironment modulation.

Insights
IOBT   positive

Company presented promising pre-clinical data for two new vaccine candidates, highlighting potential advancements in cancer immunotherapy and plans to file an Investigational New Drug Application in 2026